The S100A8 and S100A9 Proteins are Attractive Targets to Modulate Inflammation

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 3, 2007-08 ,pp. : 244-251

Bentham Science Publishers

Access to resources Recommend Favorite

S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 2, 2015-06 ,pp. : 97-104

Bentham Science Publishers

Access to resources Recommend Favorite

S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast

By  

Current Cancer Drug Targets, Vol. 8, Iss. 4, 2008-06 ,pp. : 243-252

Bentham Science Publishers

Access to resources Recommend Favorite

S100A8/A9: a mediator of severe asthma pathogenesis and morbidity?

By Halayko Andrew J.   Ghavami Saeid  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 10, 2009-10 ,pp. : 743-755

NRC Research Press

Access to resources Recommend Favorite

Apoptosis-Inducing Activity of the S100A8/A9 Heterodimer

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 4, 2009-12 ,pp. : 318-328

Bentham Science Publishers

Access to resources Recommend Favorite